| Literature DB >> 9004281 |
W K Louw1, I C Dormehl, A J van Rensburg, N Hugo, A S Alberts, O E Forsyth, G Beverley, M A Sweetlove, J Marais, M G Lötter, A van Aswegen.
Abstract
Bone-seeking radiopharmaceuticals such as ethylenediaminetetramethylene phosphonate (EDTMP) complexes of samarium-153 and holmium-166 are receiving considerable attention for therapeutic treatment of bone metastases. In this study, using the baboon experimental model, multicompartmental analysis revealed that with regard to pharmacokinetics, biodistribution, and skeletal localisation, 166Ho-EDTMP was significantly inferior to 153Sm-EDTMP and 99mTc-MDP. A more suitable 166Ho-bone-seeking agent should thus be sought for closer similarity to 153Sm-EDTMP to exploit fully the therapeutic potential of its shorter half-life and more energetic beta radiation.Entities:
Mesh：
Substances：
Year: 1996 PMID： 9004281 DOI： 10.1016/s0969-8051(96)00117-5
Source DB: PubMed Journal: Nucl Med Biol ISSN： 0969-8051 Impact factor: 2.408